Business Context and Reporting Period
Company: Astro-Med, Inc. (Note: Request metadata listed "Astronova, Inc.", but the filing text identifies the registrant as Astro-Med, Inc.)
Filing Type: Form 10-K (Annual Report)
Period Ended: January 31, 2009
Business Overview: Astro-Med designs, develops, manufactures, and distributes specialty printers, data acquisition systems, and analysis software. Operations are organized into three segments: Test & Measurement (T&M), QuickLabel Systems (QuickLabel), and Grass Technologies (GT). The company serves aerospace, automotive, life sciences, and general manufacturing markets globally, with approximately 30% of sales derived from international customers.
Key Financial Metrics
| Metric | Fiscal 2009 | Fiscal 2008 |
|---|---|---|
| Net Sales | $71,783,000 | $72,371,000 |
| Gross Profit | $31,068,000 | $31,111,000 |
| Gross Margin | 43.3% | 43.0% |
| Operating Income | $4,626,000 | $4,199,000 |
| Net Income | $2,964,000 | $4,310,000 |
| Diluted EPS | $0.40 | $0.57 |
| Cash and Cash Equivalents | $10,979,000 | $5,748,000 |
| Working Capital | $40,119,000 | $39,411,000 |
| Long-Term Debt | $0 | $0 |
| Operating Cash Flow | $6,955,000 | $2,712,000 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 0.8% to $71.8 million, driven by a 6.5% decline in domestic T&M sales (specifically Ruggedized products) and an 8.0% decline in international QuickLabel sales. This was partially offset by growth in Grass Technologies (GT) and T&M's Everest/Dash product lines.
- Profitability Pressure: Despite a slight improvement in gross margin (43.3% vs 43.0%), Net Income dropped 31.2% to $2.96 million. This was primarily due to a higher effective tax rate (35.2% vs 14.7% in 2008, which included significant one-time tax benefits from restructuring) and increased R&D spending.
- Segment Performance:
- T&M: Sales down 4.3%; Operating profit margin declined to 15.6% from 18.5% due to lower volume in Ruggedized products.
- QuickLabel: Sales down 2.0%; Operating profit margin declined to 9.8% from 11.1% due to lower printer sales and increased selling/R&D costs.
- Grass Technologies: Sales up 4.9%; Operating profit margin improved significantly to 13.7% from 8.9% due to growth in clinical diagnostic systems and better cost absorption.
- Cost Reductions: In response to the global recession, the company initiated a cost reduction program in Q4 2009 involving wage freezes, layoffs, and deferred capital expenditures.
Outlook, Risks, and Contingencies
- Economic Outlook: Management notes a slowdown in customer demand, particularly in the latter months of fiscal 2009, attributed to the worldwide recession. Customers have deferred capital expenditures and curtailed consumable purchases.
- Investment Portfolio Risk: The company holds approximately $10 million in securities available for sale, including $891,000 in auction rate securities. Due to market disruptions, these securities have an unrealized loss of $109,075. Management believes the loss is temporary but notes the risk of further write-downs if credit markets deteriorate.
- Legal Contingency: A jury awarded Astro-Med over $1.1 million in damages against a former employee and new employer for violating a non-compete agreement. The defendants have appealed, and the company has not recognized this income as of January 31, 2009.
- Liquidity: The company maintains a $3.5 million unsecured bank line of credit, all of which is currently available. Cash flow from operations was strong at $6.96 million, driven by reductions in accounts receivable and inventory.
Key Facts for Investor Verification
- Auction Rate Securities: Verify the current market status and potential liquidity of the $891,000 holding in auction rate securities, which are classified as Level 3 assets and carry an unrealized loss.
- Segment Mix Shift: Monitor the continued decline in the high-margin Ruggedized product line (T&M) versus the growth in Grass Technologies to assess future margin stability.
- Cost Reduction Effectiveness: Track the impact of the Q4 2009 cost-cutting measures (layoffs, wage freezes) on operating expenses in the upcoming fiscal year.
- Legal Proceeds: Confirm the status of the appeal regarding the $1.1 million non-compete judgment to determine if the income will be recognized in future periods.
- International Exposure: Assess the impact of foreign exchange rates and global economic conditions on the 30% of revenue generated outside the U.S.